| Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy |
60 |
| Strategies to improve tumor penetration of nanomedicines through nanoparticle design |
45 |
| Near infrared quantum dots in biomedical applications: current status and future perspective |
34 |
| Nanomaterial exposure, toxicity, and impact on human health |
31 |
| Recent advances in photodynamic therapy for cancer and infectious diseases |
20 |
| Functional mesoporous silica nanoparticles for bio-imaging applications |
19 |
| Cell tracking using gold nanoparticles and computed tomography imaging |
19 |
| Nanoparticles to mediate X-ray-induced photodynamic therapy and Cherenkov radiation photodynamic therapy |
18 |
| Effects of food-borne nanomaterials on gastrointestinal tissues and microbiota |
17 |
| Functional magnetic hybrid nanomaterials for biomedical diagnosis and treatment |
17 |
| Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block |
15 |
| Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases |
15 |
| Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspective |
15 |
| Nanoscale platforms for messenger RNA delivery |
14 |
| Droplet microfluidics for high-sensitivity and high-throughput detection and screening of disease biomarkers |
14 |
| Probing the biological obstacles of nanomedicine with gold nanoparticles |
14 |
| Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite |
14 |
| Outer membrane vesicles for vaccination and targeted drug delivery |
13 |
| Double network hydrogel for tissue engineering |
13 |
| Two decades of dendrimers as versatile MRI agents: a tale with and without metals |
11 |
| Mapping of the available standards against the regulatory needs for nanomedicines |
11 |
| Mesoporous silica nanoparticles for tissue-engineering applications |
11 |
| Nanophotonic trapping: precise manipulation and measurement of biomolecular arrays |
11 |
| Nanotherapeutic systems for local treatment of brain tumors |
11 |
| Carbohydrate-based nanomaterials for biomedical applications |
10 |
| Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk |
10 |
| In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree |
10 |
| Plant viral and bacteriophage delivery of nucleic acid therapeutics |
9 |
| Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases |
8 |
| Developments in label-free microfluidic methods for single-cell analysis and sorting |
8 |
| The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective |
8 |
| Breaking free from vascular confinement: status and prospects for submicron ultrasound contrast agents |
8 |
| Microscopic considerations for optimizing silk biomaterials |
7 |
| Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting |
7 |
| Nanovaccines for cancer immunotherapy |
7 |
| Electroconductive hydrogels for biomedical applications |
7 |
| An update on carbon nanotube-enabled X-ray sources for biomedical imaging |
7 |
| The consolidation of nanomedicine |
6 |
| Application of nanotechnology in biosensors for enhancing pathogen detection |
6 |
| A hindsight reflection on the clinical studies of poly(L-glutamic acid)-paclitaxel |
6 |
| Gold nanoparticles in cardiovascular imaging |
6 |
| Envisioning the future of polymer therapeutics for brain disorders |
6 |
| Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression |
5 |
| Immunoengineering with biomaterials for enhanced cancer immunotherapy |
5 |
| Extracellular vesicles: nature's nanoparticles for improving gene transfer with adeno-associated virus vectors |
5 |
| Antibody and antibody derivatives as cancer therapeutics |
4 |
| Poly(lactic-co-glycolic acid) devices: Production and applications for sustained protein delivery |
4 |
| Methodologies and approaches for the analysis of cell-nanoparticle interactions |
4 |
| Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices |
4 |
| In vitro to in vivo benchmark dose comparisons to inform risk assessment of quantum dot nanomaterials |
4 |
